Interestingly, C-peptide infusion during Pd1 (euglycemic period) reduced this suppressive effect on glucagon secretion, pointing toward a capability of preserving basal glucagon levels during hyperinsulinemia, which could be of benefit to insulin-requiring individuals between meals or while they sleep. This evidence concerns the gene INS and Hyperinsulinemia.